Suchergebnisse - "Drug Therapy, Combination"

PubPharm (710)

51

Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension

enthalten in: Herz | 2023

von Lange, T.

52

Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension

enthalten in: Herz | 2023

von Lange, T.

53

Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension

enthalten in: Herz | 2023

von Lange, T.

54

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

enthalten in: ESMO open | 2023

von Hecht, J. | Raman, S. | Chan, A. | +15

55

An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer

enthalten in: Journal for immunotherapy of cancer | 2023

von Wittwer, N. | Staudacher, A. | Liapis, V. | +3

56

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy

enthalten in: Journal for immunotherapy of cancer | 2023

von Rizvi, N. | Ademuyiwa, F. | Cao, Z. | +10

57

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors

enthalten in: Journal for immunotherapy of cancer | 2023

von Kluger, H. | Barrett, J. | Gainor, J. | +8

58

Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies

enthalten in: Journal for immunotherapy of cancer | 2023

von Atkins, M. | Ascierto, P. | Feltquate, D. | +8

59

Gray zone lymphoma : five cases report and literature review

enthalten in: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 2023

von Zou, H. | Zhang, H. | Liu, H. | +9

60

Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression

enthalten in: Journal for immunotherapy of cancer | 2023

von Bruni, S. | Mauro, F. | Proietti, C. | +21